Bio-Rad Laboratories, Inc. Stock Deutsche Boerse AG
Stocks
BUWA
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
14:17:51 17/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 332.40 EUR | +0.61% |
|
+2.04% | +29.16% |
| Market Cap | 10.06B 8.72B 8.24B 7.48B 14.03B 965B 14.11B 98.41B 38.03B 490B 37.81B 36.97B 1,561B | P/E 2026 * |
45.6x | P/E 2027 * | 44.5x |
|---|---|---|---|---|---|
| Enterprise Value | 9.31B 8.07B 7.63B 6.93B 12.98B 894B 13.06B 91.08B 35.2B 453B 34.99B 34.21B 1,445B | EV / Sales 2026 * |
3.62x | EV / Sales 2027 * | 3.46x |
| Free-Float |
60.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO | Delayed | |
CBOE
| BIO | Real-time | |
|
Deutsche Boerse AG
| BUWA | Delayed | |
|
Tradegate
| BUWA | Real-time | |
|
Börse Stuttgart
| BUWA | Delayed | |
|
Boerse Muenchen
| BUWA | Real-time |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +0.58% | ||
| 1 week | +2.04% | ||
| Current month | -0.72% | ||
| 1 month | +7.55% | ||
| 3 months | +32.27% | ||
| 6 months | +46.26% | ||
| Current year | +29.16% |
| 1 week | 316.2 |  | 330.8 |
| 1 month | 300.8 | | 338.4 |
| Current year | 204.6 | | 338.4 |
| 1 year | 204.6 | | 338.4 |
| 3 years | 187.35 | | 351.8 |
| 5 years | 187.35 | | 690 |
| 10 years | 138.79 | | 700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.61% | +2.04% | - | - | 10.06B | |
| +0.32% | -2.73% | -22.90% | +0.61% | 177B | |
| -1.23% | +0.77% | -1.69% | +13.24% | 118B | |
| -1.48% | -1.49% | +9.83% | +78.64% | 60.78B | |
| -2.19% | +1.14% | -2.34% | -31.05% | 49.53B | |
| +1.32% | -1.97% | +6.33% | +40.91% | 48.29B | |
| +1.03% | +4.12% | +14.10% | -9.35% | 32.96B | |
| +2.74% | -3.11% | - | - | 28.94B | |
| -0.82% | +7.44% | +40.12% | -8.16% | 25.48B | |
| +2.05% | +1.73% | +10.61% | -23.63% | 21.77B | |
| Average | +0.19% | +0.55% | +6.76% | +7.65% | 62.59B | |
| Weighted average by Cap. | -0.26% | -0.55% | -3.28% | +10.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.23B 2.11B 1.91B 3.59B 247B 3.61B 25.16B 9.72B 125B 9.67B 9.45B 399B | 2.63B 2.28B 2.16B 1.96B 3.67B 253B 3.69B 25.75B 9.95B 128B 9.89B 9.67B 408B |
| Net income | 225M 195M 184M 167M 313M 21.57B 315M 2.2B 850M 10.94B 845M 826M 34.87B | 230M 199M 188M 171M 320M 22.04B 322M 2.25B 868M 11.18B 863M 844M 35.63B |
| Net Debt | -749M -649M -614M -557M -1.04B -71.85B -1.05B -7.32B -2.83B -36.45B -2.81B -2.75B -116B | -965M -837M -791M -718M -1.35B -92.61B -1.35B -9.44B -3.65B -46.97B -3.63B -3.55B -150B |
| Date | Price | Change |
|---|---|---|
| 17/09/26 | €330.40 | +0.98% |
| 15/09/26 | €327.20 | +2.38% |
| 14/09/26 | €319.60 | +0.38% |
| 11/09/26 | €318.40 | +0.25% |
| 10/09/26 | €317.60 | -1.91% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BUWA Stock
Select your edition
All financial news and data tailored to specific country editions
